Wird geladen...
A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis
INTRODUCTION: Natalizumab is a new humanized monoclonal antibody used in multiple sclerosis (MS). The aim of this meta-analysis was to evaluate the efficacy and tolerability of this drug in relapsing MS. PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials were searched...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Termedia Publishing House
2010
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3281346/ https://ncbi.nlm.nih.gov/pubmed/22371753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2010.13901 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|